Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Plasmonic Resonance Technique Detects Breast Cancer Marker in Single Cells

By BiotechDaily International staff writers
Posted on 07 May 2014
Image: Schema of surface plasmon resonance (Photo courtesy of Wikimedia Commons).
Image: Schema of surface plasmon resonance (Photo courtesy of Wikimedia Commons).
A nano-technique based on DNA-tagged gold nanoparticles was used to detect and quantify splice variants of BRCA1 messenger RNA (mMRNA) at the level of single cells.

BRCA1 (breast cancer 1, early onset) is a human caretaker gene that produces a protein called breast cancer type 1 susceptibility protein, responsible for repairing DNA. BRCA1 is expressed in the cells of breast and other tissue, where it helps repair damaged DNA or destroy cells if DNA cannot be repaired. If BRCA1 does not function properly, damaged DNA is not repaired, and this increases risks for cancers.

The presence of BRCA1 mRNA splice variants is a marker for the type of gene expression failure that might lead to development of breast cancer, but there is currently a lack of quantitative technologies for monitoring mRNA splice variants in cells.

Investigators at Purdue University (West Lafayette, IN, USA) reported that a combination of plasmonic gold nanoparticle dimer probes and hyperspectral imaging could be used to detect and quantify mRNA splice variants in living cells. The probes were made from gold nanoparticles functionalized with oligonucleotides designed to hybridize to specific BRACA1 mRNA splice variant sequences, forming nanoparticle dimers that exhibited distinct spectral shifts due to plasmonic coupling.

Plasmonic resonance is a phenomenon that occurs when light is reflected off thin metal films, which may be used to measure interaction of biomolecules on the surface. An electron charge density wave arises at the surface of the film when light is reflected at the film under specific conditions. A fraction of the light energy incident at a defined angle can interact with the delocalized electrons in the metal film (plasmon) thus reducing the reflected light intensity. The angle of incidence at which this occurs is influenced by the refractive index close to the backside of the metal film, to which target molecules are immobilized. If ligands in a mobile phase running along a flow cell bind to the surface molecules, the local refractive index changes in proportion to the mass being immobilized. This can be monitored in real time by detecting changes in the intensity of the reflected light. This property allowed the investigators to distinguish between free gold particles and those bound to BRACA1 mRNA.

Results published in the April 20, 2014, online edition of the journal Nature Nanotechnology revealed that a combination of spectroscopy and advanced digital colorimetric image techniques could distinguish between free gold nanoparticles and those bound to strands of mRNA (dimers) and monitor the spatial and temporal distribution of three selected BRCA1 mRNA splice variants at single-copy resolution.

"This is a simple yet sophisticated technique that can be used to detect cancer in a single cell and determine how aggressive it is," said senior author Dr. Joseph Irudayaraj, professor of agricultural and biological sciences at Purdue University. "Being able to quantify these genetic molecules could ultimately help clinicians provide better and more individualized treatment to cancer patients."

"With this method, we are basically able to spot a needle in a haystack - and we can determine if there are 5 needles in that haystack or if there are 50," said Dr. Irudayaraj. "If we can quantify key mRNA at single cell resolution in a tissue biopsy, that will be very powerful in terms of refining treatment protocols for key diseases."

Related Links:

Purdue University



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Alternative splicing produces two protein isoforms (Photo courtesy of Wikimedia Commons).

Key Regulator of Cancer-Inducing Alternative Splicing Identified

Cancer researchers have identified the splicing factor RBM4 (RNA-binding protein 4) as a key determinant in processes that prevent tumor development and spread. RBM4 is known to be crucial to gene splicing... Read more

Drug Discovery

view channel

Ibuprofen May Restore Immune Function in Older Individuals

New research suggests that macrophages from the lungs of old mice respond differently to infections than those of young mice, and ibuprofen given to the mice reversed these changes. New research using lab mice suggests that the solution to more youthful immune function might already be a common over-the-counter pain reliever.... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.